The Apex Times
Above the Noise
Business Wire
BusinessEli Lilly to buy Merida Biosciences for $2.88 billion, setting off investor focus on the deal’s strategic fitThe Apex TimesBusinessApple says it has evidence a former employee destroyed material after learning of an investigationThe Apex TimesBusinessTelecom comparison turns on profitability pace versus leverage: AT&T’s margin jump, Verizon’s debt loadThe Apex TimesBusinessAnthropic agrees to a $35 billion cloud computing deal tied to Nvidia-backed Lambda, report saysThe Apex TimesBusinessAMD has tended to fall in September, but market history is only part of the storyThe Apex TimesBusinessDuolingo shares jump after results point to steady user momentum, according to Yahoo FinanceThe Apex TimesBusinessNetflix confirms production of Korean series “Materesa (WT),” led by “Queen of Tears” director and writers behind “The East Palace”The Apex TimesBusinessFTC and 22 States Sue Amazon, Alleging It Secretly Marked Up Ads Shown to Marketplace SellersThe Apex TimesBusinessDeere shares gained as market focused on a jump in profitsThe Apex TimesBusinessBaird lifts Deere to Outperform, citing potential agricultural recovery and raises target to $800The Apex TimesBusinessVenezuela’s energy reopening talks could create upside for Chevron and GE Vernova, but agreements still face major hurdlesThe Apex TimesBusinessTrump Says ExxonMobil Is Preparing to Re-enter Venezuela as Investment Outlook ShiftsThe Apex TimesBusinessEli Lilly to buy Merida Biosciences for $2.88 billion, setting off investor focus on the deal’s strategic fitThe Apex TimesBusinessApple says it has evidence a former employee destroyed material after learning of an investigationThe Apex TimesBusinessTelecom comparison turns on profitability pace versus leverage: AT&T’s margin jump, Verizon’s debt loadThe Apex TimesBusinessAnthropic agrees to a $35 billion cloud computing deal tied to Nvidia-backed Lambda, report saysThe Apex TimesBusinessAMD has tended to fall in September, but market history is only part of the storyThe Apex TimesBusinessDuolingo shares jump after results point to steady user momentum, according to Yahoo FinanceThe Apex TimesBusinessNetflix confirms production of Korean series “Materesa (WT),” led by “Queen of Tears” director and writers behind “The East Palace”The Apex TimesBusinessFTC and 22 States Sue Amazon, Alleging It Secretly Marked Up Ads Shown to Marketplace SellersThe Apex TimesBusinessDeere shares gained as market focused on a jump in profitsThe Apex TimesBusinessBaird lifts Deere to Outperform, citing potential agricultural recovery and raises target to $800The Apex TimesBusinessVenezuela’s energy reopening talks could create upside for Chevron and GE Vernova, but agreements still face major hurdlesThe Apex TimesBusinessTrump Says ExxonMobil Is Preparing to Re-enter Venezuela as Investment Outlook ShiftsThe Apex TimesBusinessEli Lilly to buy Merida Biosciences for $2.88 billion, setting off investor focus on the deal’s strategic fitThe Apex TimesBusinessApple says it has evidence a former employee destroyed material after learning of an investigationThe Apex TimesBusinessTelecom comparison turns on profitability pace versus leverage: AT&T’s margin jump, Verizon’s debt loadThe Apex TimesBusinessAnthropic agrees to a $35 billion cloud computing deal tied to Nvidia-backed Lambda, report saysThe Apex TimesBusinessAMD has tended to fall in September, but market history is only part of the storyThe Apex TimesBusinessDuolingo shares jump after results point to steady user momentum, according to Yahoo FinanceThe Apex TimesBusinessNetflix confirms production of Korean series “Materesa (WT),” led by “Queen of Tears” director and writers behind “The East Palace”The Apex TimesBusinessFTC and 22 States Sue Amazon, Alleging It Secretly Marked Up Ads Shown to Marketplace SellersThe Apex TimesBusinessDeere shares gained as market focused on a jump in profitsThe Apex TimesBusinessBaird lifts Deere to Outperform, citing potential agricultural recovery and raises target to $800The Apex TimesBusinessVenezuela’s energy reopening talks could create upside for Chevron and GE Vernova, but agreements still face major hurdlesThe Apex TimesBusinessTrump Says ExxonMobil Is Preparing to Re-enter Venezuela as Investment Outlook ShiftsThe Apex TimesBusinessEli Lilly to buy Merida Biosciences for $2.88 billion, setting off investor focus on the deal’s strategic fitThe Apex TimesBusinessApple says it has evidence a former employee destroyed material after learning of an investigationThe Apex TimesBusinessTelecom comparison turns on profitability pace versus leverage: AT&T’s margin jump, Verizon’s debt loadThe Apex TimesBusinessAnthropic agrees to a $35 billion cloud computing deal tied to Nvidia-backed Lambda, report saysThe Apex TimesBusinessAMD has tended to fall in September, but market history is only part of the storyThe Apex TimesBusinessDuolingo shares jump after results point to steady user momentum, according to Yahoo FinanceThe Apex TimesBusinessNetflix confirms production of Korean series “Materesa (WT),” led by “Queen of Tears” director and writers behind “The East Palace”The Apex TimesBusinessFTC and 22 States Sue Amazon, Alleging It Secretly Marked Up Ads Shown to Marketplace SellersThe Apex TimesBusinessDeere shares gained as market focused on a jump in profitsThe Apex TimesBusinessBaird lifts Deere to Outperform, citing potential agricultural recovery and raises target to $800The Apex TimesBusinessVenezuela’s energy reopening talks could create upside for Chevron and GE Vernova, but agreements still face major hurdlesThe Apex TimesBusinessTrump Says ExxonMobil Is Preparing to Re-enter Venezuela as Investment Outlook ShiftsThe Apex Times
Back to front
Johnson & Johnson wins a talc-cancer lawsuit after a Los Angeles jury finds no negligence
The Apex Times

THE APEX TIMES

Business/The Apex Times/Jun 28, 4:16 PM EDT

Johnson & Johnson wins a talc-cancer lawsuit after a Los Angeles jury finds no negligence

A Los Angeles jury ruled in favor of Johnson & Johnson in a lawsuit alleging talc products caused cancer in three women, according to a Reuters report carried by Yahoo Finance.

By The Apex Times Newsroom2 min readAI-assisted Apex article

Johnson & Johnson said it prevailed in a lawsuit in Los Angeles that alleged the company’s talc products caused cancer in three women. The case, reported by Reuters and republished by Yahoo Finance, ended with a jury finding that Johnson & Johnson was not negligent.

The dispute centered on allegations that talc exposure led to the women’s illnesses. Reuters characterized the jury’s decision as a rejection of the plaintiffs’ negligence theory, with the jury concluding Johnson & Johnson did not act negligently with respect to the talc at issue.

While the Reuters report, as presented in the Yahoo Finance posting, describes the jury outcome, it did not add in the available text what specific products were named, what medical diagnoses were involved, or the damages the plaintiffs sought. Those details, which often matter in talc litigation, were not included in the material available here.

Johnson & Johnson has faced repeated lawsuits involving claims that talc is linked to ovarian cancer and other conditions. In the Reuters account referenced by Yahoo Finance, the immediate legal takeaway is straightforward: a jury declined to find Johnson & Johnson liable under the allegations presented at trial.

For Johnson & Johnson, outcomes like this can affect the rhythm of its broader litigation over talc. Even when a case ends without liability, new suits and appeals can continue, and results in one venue do not automatically change outcomes elsewhere.

Still, the practical significance of this particular verdict depends on what happens next. The plaintiffs can typically seek post-trial relief or appeal, and juries in other trials may reach different conclusions based on differing evidence, expert testimony, and product timelines. The available report does not indicate whether either side has indicated an intent to appeal or how the company plans to frame the decision publicly.

Why It Matters

  • A jury finding of no negligence reduces liability exposure in the specific case, even as talc litigation can continue across jurisdictions.
  • For companies in this category, trial outcomes can influence how claims are assessed by plaintiffs’ counsel, insurers, and defendants in related matters.
  • How both sides pursue post-trial steps, including any appeal, will determine whether the decision has longer-term impact beyond this venue.

Sources

Key Facts

  • A Los Angeles jury found Johnson & Johnson was not negligent in a lawsuit alleging talc caused cancer in three women.
  • The verdict was reported by Reuters and carried by Yahoo Finance on June 28, 2026.
  • The available report material does not specify which talc products were at issue or the medical diagnoses involved.
  • The case outcome rejects the plaintiffs’ negligence theory as presented at trial.

Healthcare Related

Johnson & Johnson wins a talc-cancer lawsuit after a Los Angeles jury finds no negligence | The Apex Times